BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10446812)

  • 1. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
    Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN
    J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
    Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
    Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
    Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Hayakawa T
    Neurol Med Chir (Tokyo); 1997 Aug; 37(8):606-10; discussion 611. PubMed ID: 9301196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
    Oskam NT; Bijleveld EH; Hulsebos TJ
    Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer.
    Iida A; Kurose K; Isobe R; Akiyama F; Sakamoto G; Yoshimoto M; Kasumi F; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):108-12. PubMed ID: 9491321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A; Louis DN; von Ammon K; Petersen I; Wiestler OD; Seizinger BR
    Cancer Res; 1992 Aug; 52(15):4277-9. PubMed ID: 1353411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
    Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A
    Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.
    Zhou CZ; Peng ZH; Zhang F; Qiu GQ; He L
    World J Gastroenterol; 2002 Aug; 8(4):668-73. PubMed ID: 12174376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity on chromosome 22 in human ependymomas.
    Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
    Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
    Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
    Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression-associated gene regions in astrocytomas: a candidate locus on chromosome 19q].
    von Deimling A; Albrecht S; Wiestler OD
    Verh Dtsch Ges Pathol; 1994; 78():423-6. PubMed ID: 7534013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
    Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion mapping of chromosome 19 in human gliomas.
    von Deimling A; Nagel J; Bender B; Lenartz D; Schramm J; Louis DN; Wiestler OD
    Int J Cancer; 1994 Jun; 57(5):676-80. PubMed ID: 8194874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours.
    Miyakawa A; Ichimura K; Schmidt EE; Varmeh-Ziaie S; Collins VP
    Br J Cancer; 2000 Feb; 82(3):543-9. PubMed ID: 10682663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer.
    Castells A; Ino Y; Louis DN; Ramesh V; Gusella JF; Rustgi AK
    Gastroenterology; 1999 Oct; 117(4):831-7. PubMed ID: 10500065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
    Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
    Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of cytogenetic analysis and loss of heterozygosity studies in human diffuse astrocytomas and mixed oligo-astrocytomas.
    Ransom DT; Ritland SR; Moertel CA; Dahl RJ; O'Fallon JR; Scheithauer BW; Kimmel DW; Kelly PJ; Olopade OI; Diaz MO
    Genes Chromosomes Cancer; 1992 Nov; 5(4):357-74. PubMed ID: 1283325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.